References
- Chen, Y. L., Chun, L. L., & Enscore, D. J. (March 4, 1986). Transdermal Therapeutic Systems for the Administration of Naloxone, Naltrexone, and Nalbuphine. Alza US Patent #4,573,995.
- Cone, E. J., Gorodetzky, C. W., & Yeh, S. Y. (1974). The urinary excretion profile of naltrexone and metabolites in man.Drug Metab. Dispos., 2, 506–512., [PUBMED], [INFOTRIEVE], [CSA]
- Hussain, M. A., Koval, C. A., Myers, M. J., Shami, E. G., & Shefter, E. (1987). Improvement of the oral bioavailability of naltrexone in dogs.J. Pharm. Sci., 76, 356–358., [PUBMED], [INFOTRIEVE], [CSA]
- Hussain, M. A., Aungst, B. J., Koval, C. A., & Shefter, E. (1988). Improved buccal delivery of opioid analgesics and antagonists with bitterless prodrugs.Pharm. Res., 5, 615–618., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kranzler, H. R., Lowe, V. M., & Kirk, J. V. (2000). Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.Neuropsychopharmacology, 22, 493–503., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Meyer, M. C., Straughn, A. B., Lo, M. W., Schary, W. L., & Whitney, C. C. (1984). Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.J. Clin. Psychiatry, 45, 15–19., [PUBMED], [INFOTRIEVE], [CSA]
- Pillai, O., Hamad, M. O., Crooks, P. A., & Stinchcomb, A. L. (2004). Physicochemical evaluation, in vitro human skin diffusion, and concurrent biotransformation of 3-O-alkyl carbonate prodrugs of naltrexone.Pharm. Res., 21, 1146–1152., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Stinchcomb, A. L., Swaan, P. W., Ekabo, O., Harris, K. E., Browe, J., Hammell, D. C., Cooperman, T. A., & Pearsall, M. (2002). Straight-chain naltrexone ester prodrugs: diffusion and concurrent biotransformation in human skin.J. Pharm. Sci., 91, 2571–2578., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Terenius, L. (1998). Rational treatment of addiction.Curr. Opin. Chem. Biol., 2, 541–547., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Vereby, K., Volavka, J., Mule, S. J., & Resnick, R. B. (1976). Naltrexone: disposition, metabolism and effects after acute and chronic dosing.Clin. Pharmacol. Ther., 20, 315–328., [CSA]
- Volpicelli, J. R., Alterman, A. I., & Hayashida, M. (1992). Naltrexone in the treatment of alcohol dependence.Arch. Gen. Psychiatry, 49, 876–880., [PUBMED], [INFOTRIEVE], [CSA]
- Wall, M., Brine, D. R., & Perez Reyes, M. (1981). Metabolism and disposition of naltrexone in man after oral and intravenous administration.Drug Metab. Dispos., 9, 369–375., [PUBMED], [INFOTRIEVE], [CSA]